Details for Patent: 8,022,228
✉ Email this page to a colleague
Title: | Crystal form of asenapine maleate |
Abstract: | The invention relates to an orthorhombic crystal form of compound trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4- ,5-c]pyrrole(Z)-2-butenedioate, to methods for the preparation of this crystal form and to pharmaceutical compositions comprising an orthorhombic crystal form. |
Inventor(s): | Heeres; Gerhardus Johannes (Oss, NL) |
Assignee: | N.V. Organon (Oss, NL) |
Filing Date: | Nov 13, 2007 |
Application Number: | 11/939,023 |
Claims: | 1. The compound trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4- ,5-c]pyrrole(Z)-2-butenedioate, wherein the compound is in a microcrystalline orthorhombic crystal form. 2. The microcrystalline form of the compound according to claim 1 which has a particle size distribution yielding a d95 value less than or equal to about 100 microns. 3. The microcrystalline form of the compound according to claim 2 which yields an X-ray powder diffraction pattern obtained with CuK.alpha. (radiation having peaks at values of 2-theta (20) of 10.5.degree. and 15.7.degree.. 4. The compound according to claim 1 which is characterized by an X-ray powder diffraction pattern obtained with CuK.alpha. radiation with peaks at values of 2-theta (2.theta.) of 10.5.degree., 15.7.degree., 18.3.degree., 19.0.degree., 22.2.degree., 23.2.degree. and 27.5.degree.. 5. A process for preparing an orthorhombic microcrystalline form trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4- -5,c]pyrrole(Z)-2-butenedioate, wherein the orthorhombic microcrystalline form of the compound is at least about 90 wt. % of compound, the process comprising crystallizing the compound from an ethanol/water mixture which is in a 9:1 volume proportion and micronizing said crystalline material thus obtained. 6. The microcrystalline form of the compound according to claim 2 which has a particle size distribution yielding a d95 value of less than or equal to about 50 microns. 7. The microcrystalline form of the compound according to claim 2 which has a particle size distribution yielding a d95 value of less than or equal to about 30 microns. |